Central Data Catalog


1 Korenromp, E. L., R. G. White, K. K. Orroth, R. Bakker, A. Kamali, D. Serwadda, R. H. Gray, H. Grosskurth, J. D. F. Habbema, and R. J. Hayes. "Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials." J. Infect. Dis. (2005).
2 McCormack, Sheena, Gita Ramjee, Anatoli Kamali, Helen Rees, Angela M Crook, Mitzy Gafos, Ute Jentsch, Robert Pool, Maureen Chisembele, Saidi Kapiga, Richard Mutemwa, Andrew Vallely, Thesla Palanee, Yuki Sookrajh, Charles J Lacey, Janet Darbyshire, Heiner Grosskurth, Albert Profy, Andrew Nunn, Richard Hayes, and Jonathan Weber. "PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial." Lancet 376, no. 9749 (2010): 1329-1337.
3 Orroth, K. K., E. L. Korenromp, R. G. White, J. Changalucha, S. J. de Vlas, R. H. Gray, P. Hughes, A. Kamali, A. Ojwiya, D. Serwadda, M. J. Wawer, R. J. Hayes, and H. Grosskurth. "Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors." Sex Transm Infect (2003).
4 White, Richard G., Kate K. Orroth, Eline L. Korenromp, Roel Bakker, Mwita Wambura, Nelson K. Sewankambo, Ron H. Gray, Anatoli Kamali, James A. G. Whitworth, Heiner Grosskurth, J. Dik F. Habbema, and Richard J. Hayes. "Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study." J. Acquir. Immune Defic. Syndr. (2004).